Rapid ischemic tolerance induced by adenosine preconditioning results in Bcl-2 interacting mediator of cell death (Bim) degradation by the proteasome

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 2, Issue 1, 2010, Pages 36-44

  Ordonez, Andrea Nicole ^a   Jessick, Veronica Joy ^a   Clayton, Corrin Erin ^a   Ashley, Michelle Dawn ^a   Thompson, Simon John ^a   Simon, Roger Pancoast ^a   Meller, Robert ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

Adenosine; Bcl 2; Proteasome; Rapid ischemic tolerance; Ubiquitin

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE RECEPTOR STIMULATING AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BIM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N 6 (2 PHENYLISOPROPYL)ADENOSINE; PROTEASOME; UNCLASSIFIED DRUG; UO 126;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; UBIQUITINATION;

EID: 77953391745     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dirnagl U, Simon RP and Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248-254.
2. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X and Simon RP. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003; 362: 1028-1037.
3. Kuroiwa T, Yamada I, Endo S, Hakamata Y and Ito U. 3-Nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils. Neuroscience Letters 2000; 283: 145-148.
4. Weih M, Bergk A, Isaev NK, Ruscher K, Megow D, Riepe M, Meisel A, Victorov IV and Dirnagl U. Induction of ischemic tolerance in rat cortical neurons by 3-nitropropionic acid: chemical preconditioning. Neuroscience Letters 1999; 272: 207-210.
5. Loftus LT, Gala R, Yang T, Jessick VJ, Ashley MD, Ordonez AN, Thompson SJ, Simon RP and Meller R. Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance. Brain Res 2009; 1272: 71-80.
6. Emerson MR, Nelson SR, Samson FE and Pazdernik TL. A global hypoxia preconditioning model: neuroprotection against seizure-induced specific gravity changes (edema) and brain damage in rats. Brain Res Brain Res Protoc 1999; 4: 360-366.
7. Ota A, Ikeda T, Xia XY, Xia YX and Ikenoue T. Hypoxic-ischemic tolerance induced by hyperthermic pretreatment in newborn rats. J Soc Gynecol Investig 2000; 7: 102-105.
8. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K and et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990; 528: 21-24.
9. Towfighi J, Housman C, Mauger D and Vannucci RC. Effect of seizures on cerebral hypoxicischemic lesions in immature rats. Brain Res Dev Brain Res 1999; 113: 83-95.
10. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X and Feuerstein GZ. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 1998; 29: 1937-1950; discussion 1950-1931
11. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC and Simon RP. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 2005; 25: 234-246.
12. Dhodda VK, Sailor KA, Bowen KK and Vemuganti R. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 2004; 89: 73-89.
13. Meller R, Cameron JA, Torrey DJ, Clayton CE, Ordonez AN, Henshall DC, Minami M, Schindler CK, Saugstad JA and Simon RP. Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons. J Biol Chem 2006; 281: 7429-7436.
14. Perez-Pinzon MA, Xu GP, Mumford PL, Dietrich WD, Rosenthal M and Sick TJ. Rapid ischemic preconditioning protects rats from cerebral anoxia/ischemia. Adv Exp Med Biol 1997; 428: 155-161.
15. Reshef A, Sperling O and Zoref-Shani E. Opening of ATP-sensitive potassium channels by cromakalim confers tolerance against chemical ischemia in rat neuronal cultures. Neurosci Lett 1998; 250: 111-114.
16. Reshef A, Sperling O and Zoref-Shani E. Role of K(ATP) channels in the induction of ischemic tolerance by the 'adenosine mechanism' in neuronal cultures. Adv Exp Med Biol 2000; 486: 217-221.
17. Reshef A, Sperling O and Zoref-Shani E. Preconditioning of primary rat neuronal cultures against ischemic injury: characterization of the "time window of protection'. Brain Res 1996; 741: 252-257.
18. Perez-Pinzon MA, Mumford PL, Rosenthal M and Sick TJ. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience 1996; 75: 687-694.
19. Liu Y, Xiong L, Chen S and Wang Q. Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can J Anaesth 2006; 53: 194-201.
20. Perez-Pinzon MA and Born JG. Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C. Neuroscience 1999; 89: 453-459.
21. Meller R, Thompson SJ, Lusardi TA, Ordonez AN, Ashley MD, Jessick V, Wang W, Torrey DJ, Henshall DC, Gafken PR, Saugstad JA, Xiong ZG and Simon RP. Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism under-lying rapid ischemic tolerance. J Neurosci 2008; 28: 50-59.
22. Bossenmeyer-Pourie C and Daval JL. Prevention from hypoxia-induced apoptosis by preconditioning: a mechanistic approach in cultured neurons from fetal rat forebrain. Brain Res Mol Brain Res 1998; 58: 237-239.
23. Minami M, Jin KL, Li W, Nagayama T, Henshall DC and Simon RP. Bcl-w expression is increased in brain regions affected by focal cerebral ischemia in the rat. Neurosci Lett 2000; 279: 193-195.
24. Kato K, Shimazaki K, Kamiya T, Amemiya S, Inaba T, Oguro K and Katayama Y. Differential effects of sublethal ischemia and chemical preconditioning with 3-nitropropionic acid on protein expression in gerbil hippocampus. Life Sci 2005; 77: 2867-2878.
25. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR and Newmeyer DD. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005; 17: 525-535.
26. Ley R, Balmanno K, Hadfield K, Weston C and Cook SJ. Activation of the ERK1/2 Signaling Pathway Promotes Phosphorylation and Proteasome-dependent Degradation of the BH3-only Protein, Bim. J Biol Chem 2003; 278: 18811-18816.
27. Putcha G, Le, S, Frank, S, Besirli, CG, Clark, K, Chu, B, Alix, S, Youle, RJ, LaMarche, A, Maroney, AC, Johnson, EM. JNK-Mediated BIM Phosphorylation Potentiates BAX-Dependent Apoptosis. Neuron. 2003; 38: 899-914.
28. Shinoda S, Schindler CK, Meller R, So NK, Araki T, Yamamoto A, Lan JQ, Taki W, Simon RP and Henshall DC. Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. J Clin Invest 2004; 113: 1059-1068.
29. Nakamura M, Nakakimura K, Matsumoto M and Sakabe T. Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist. J Cereb Blood Flow Metab 2002; 22: 161-170.
30. Ley R, Ewings KE, Hadfield K, Howes E, Balmanno K and Cook SJ. Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J Biol Chem 2004; 279: 8837-8847.
31. Reshef A, Sperling O and Zoref-Shani E. Opening of K(ATP) channels is mandatory for acquisition of ischemic tolerance by adenosine. Neuroreport 2000; 11: 463-465.
32. Ley R, Hadfield K, Howes E and Cook SJ. Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimEL. J Biol Chem 2005; 280: 17657-17663.
33. Kline MP, Rajkumar SV, Timm MM, Kimlinger TK, Haug JL, Lust JA, Greipp PR and Kumar S. ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells. Leukemia 2007; 21: 1549-1560.